Adam Savage, Ph.D.
Combining a commitment to the Allen Institute's overall mission with an interest in human and translational immunology, Adam joined the Allen Institute for Immunology in mid-2018. He helped to build the early collaborative relationships with external partners as well as research and assay plans, particularly the flow cytometry assays used across all of the Institute's studies. Currently, he focuses on hypotheses and experimentation in the realms of health and autoimmunity, and continues to contribute to scientific goals across the various teams at the Allen Institute for Immunology.
Adam's post-doctoral work, with Dr. Rich Locksley at UCSF, focused on immune development and immune-tissue cross-talk at the intestinal epithelial barrier. He received a Ph.D. from the University of Chicago for work on the transcriptional regulation of innate-like T cells with Dr. Albert Bendelac, an MFA from Sarah Lawrence College, and a B.A. from the University of Wisconsin-Madison. He is guided by the principle that the immune system is an integral partner of healthy tissue as well as a potent mediator of immunity and pathology, and he’s excited to contribute to the Allen Institute's efforts to positively impact human health and disease.
May 21, 2021
Savage AK, Gutschow MV, Chiang T, Henderson K, Green R, Chaudhari M, Swanson E, Heubeck AT, Kondza N, Burley KC, Genge PC, Lord C, Smith T, Thomson Z, Beaubien A, Johnson E, Goldy J, Bolouri H, Buckner J, Meijer P, Coffey EM, Skene PJ, Torgerson TR, Li XJ, Bumol TF
April 9, 2021
Swanson E, Lord C, Reading J, Heubeck AT, Genge PC, Thomson Z, Weiss MDA, Li X, Savage AK, Green RR, Torgerson TR, Bumol TF, Graybuck LT, Skene PJ